Search results
20 hours ago · In an 18-month study of people who were in the early stages of Alzheimer’s disease, the antibody lecanemab – which the US Food and Drug Administration approved in 2023 – slowed the rate of ...
5 days ago · The safety and effectiveness of oral therapy candidate buntanetap are comparable in people with early Alzheimer’s disease regardless of whether they do or do not carry a genetic risk factor known as APOE4. That’s according to new data from a Phase 2/3 clinical trial (NCT05686044) that tested three doses of buntanetap against a placebo in ...
1 day ago · Rapamycin may slow aging. Here's one way the drug will be tested. A generic drug that's used to treat transplant patients has been shown to extend the life span of some animals. A few years back ...
15 hours ago · Lauralee Denler (at left), 60, of Old Saybrook was diagnosed with early onset Alzheimer's in 2023, that's Alzheimer's before the age of 65. She is now on a clinical trial and says she is hopeful of a bright future. Denler, her wife Tara Milardo (at right) and their son Tyler enjoy putting puzzles together.
4 days ago · But some scientists remain skeptical that the drug's effects, while measurable in clinical trials, will be noticeable to patients. Where it stands: As of January, there were 127 drugs being assessed in 164 clinical trials against Alzheimer's, according to a study published in an Alzheimer's-focused journal. Three-quarters aim to modify the ...
3 days ago · Schulz specializes in dementia. Three years ago, Schulz enrolled Rolfe as the first patient in Texas for a drug trial designed to destroy brain plaque linked to Alzheimer’s. The drug is made of ...
4 days ago · Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development.
